Chitosan microparticles as oral delivery system for tetanus toxoid

被引:29
作者
Ahire, Vijay J. [1 ]
Sawant, Krutika K.
Doshi, Jignesh B.
Ravetkar, Satish D.
机构
[1] Maharaja Sayajirao Univ Baroda, Dept Pharm, TIFAC CORE NDDS, Ctr Relevance & Excellence New Drug Delivery Syst, Vadodara, India
[2] Serum Inst India Pvt Ltd, Toxoid Purificat Dept, Pune, Maharashtra, India
关键词
chitosan; tetanus toxoid; mucosal and systemic immunity;
D O I
10.1080/03639040701377847
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Systemic and local immune response against Chitosan encapsulated tetanus toxoid (CS-TT) microparticles is studied, prepared by ionic cross-linking using Sodium Tripolyphosphate (STPP). Final formulation was evaluated in terms of release of TT in 0.1 N HCl and PBS ( pH 7.4), sedimentation profile and stability. CS-TT microparticles, TT in PBS and plain CS microparticles were orally administered to mice and TT (adsorbed) was administered through intramuscular route. Sera were analyzed for anti-TT IgG and intestinal lavage, faeces, intestinal washings for anti-TT IgA levels using an ELISA. Entrapment efficiency of about 100% was obtained. A dose dependent immune response was observed in mice vaccinated with Chitosan-TT microparticles. A strong enhancement of the systemic and local immune response against TT were found when compared with oral feeding of TT in PBS. The study shows the efficacy of chitosan microparticle suspension system, containing a high molecular protein ( TT), in inducing the IgA in intestine and IgG in systemic circulation. This demonstrates that chitosan microparticles can prove to be a promising oral vaccine delivery system for mucosal and systemic immunity.
引用
收藏
页码:1112 / 1124
页数:13
相关论文
共 42 条
[1]   Development of rocket electrophoresis technique as an analytical tool in preformulation study of tetanus vaccine formulation [J].
Ahire, V. J. ;
Sawant, K. K. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (07) :799-808
[2]  
Alpar HO, 1998, STP PHARMA SCI, V8, P31
[3]  
Barackman JD, 1998, STP PHARMA SCI, V8, P41
[4]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[5]   Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications [J].
Berger, J ;
Reist, M ;
Mayer, JM ;
Felt, O ;
Peppas, NA ;
Gurny, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) :19-34
[6]   A spectroscopic and viscometric study of the metal ion-induced gelation of the biopolymer chitosan [J].
Brack, HP ;
Tirmizi, SA ;
Risen, WM .
POLYMER, 1997, 38 (10) :2351-2362
[7]  
BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149
[8]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[9]  
2-4
[10]   Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen [J].
Chang, AC ;
Gupta, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :129-132